VEGFR-2-IN-6
≥98%
- Product Code: 109891
CAS:
444731-47-9
| Molecular Weight: | 423.49 g./mol | Molecular Formula: | C₂₀H₂₁N₇O₂S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, sealed, dry |
Product Description:
VEGFR-2-IN-6 is primarily utilized in research settings to study angiogenesis and cancer biology. It functions as a potent inhibitor of vascular endothelial growth factor receptor-2 (VEGFR-2), which plays a critical role in the formation of new blood vessels. By blocking this receptor, the compound helps in understanding the mechanisms of tumor growth and metastasis, as many cancers rely on angiogenesis for their progression. Researchers use VEGFR-2-IN-6 to explore potential therapeutic strategies for targeting cancers that are dependent on vascular development. Additionally, it serves as a tool compound in preclinical studies to evaluate the efficacy of anti-angiogenic drugs. Its application extends to investigating conditions like age-related macular degeneration and other diseases where abnormal blood vessel formation is a key factor.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | $945.09 |
+
-
|
| 0.010 | 10-20 days | $1,566.16 |
+
-
|
| 0.025 | 10-20 days | $2,970.30 |
+
-
|
VEGFR-2-IN-6
VEGFR-2-IN-6 is primarily utilized in research settings to study angiogenesis and cancer biology. It functions as a potent inhibitor of vascular endothelial growth factor receptor-2 (VEGFR-2), which plays a critical role in the formation of new blood vessels. By blocking this receptor, the compound helps in understanding the mechanisms of tumor growth and metastasis, as many cancers rely on angiogenesis for their progression. Researchers use VEGFR-2-IN-6 to explore potential therapeutic strategies for targeting cancers that are dependent on vascular development. Additionally, it serves as a tool compound in preclinical studies to evaluate the efficacy of anti-angiogenic drugs. Its application extends to investigating conditions like age-related macular degeneration and other diseases where abnormal blood vessel formation is a key factor.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :